Jubilant Cadista Pharmaceuticals Inc receives 5 observations from USFDA for Salisbury facility

Jubilant Pharmova Limited's subsidiary Jubilant Cadista Pharmaceuticals Inc., (Jubilant Cadista)'s solid oral formulations facility at Salisbury, Maryland, USA was inspected by the United States Food and Drug Administration (USFDA). USFDA has issued five observations with no repeat observations. Jubilant Cadista will submit an appropriate action plan to the USFDA on these observations within stipulated time.

Going forward the said facility is not expected to manufacture any products as it has closed manufacturing operations.

The Company has received communication from USFDA at 1.17 am (IST) on Thursday, January 16, 2025.

Shares of Jubilant Pharmova Limited was last trading in BSE at Rs. 942.10 as compared to the previous close of Rs. 921.85. The total number of shares traded during the day was 20896 in over 1742 trades.

The stock hit an intraday high of Rs. 973.55 and intraday low of 900.85. The net turnover during the day was Rs. 19811536.00.

Source : Equity Bulls

Keywords

JubilantPharmova INE700A01033 JubilantCadistaPharmaceuticals SolidOralFormulationsFacility Salisbury USFDA 5Observations